Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone-Reference-Cited by-同舟云学术

Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone

Published:2009-02-26 Issue:4 Volume:25 Page:903-910
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Blumenstein Matthias¹,Romaszko Jerzy²,Calderón Alberto³,Andersen Karl⁴,Ibram Ghionul⁵,Liu Zhaohui⁵,Zhang Jack⁵

Affiliation:

1. University of Munich, Munich, Germany

2. PANTAMED sp. z o.o., Olsztyn, Poland

3. CS Rosa Luxemburgo, Madrid, Spain

4. University of Iceland, Reykjavik, Iceland

5. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007990902804158

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinatorial approaches for novel cardiovascular drug discovery: a review of the literature;Expert Opinion on Drug Discovery;2022-07-26

2. The role of aliskiren in the management of hypertension and major cardiovascular outcomes: a systematic review and meta-analysis;Journal of Human Hypertension;2019-01-10

3. Renin Inhibition with Aliskiren: A Decade of Clinical Experience;Journal of Clinical Medicine;2017-06-09

4. Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual‐Combination Therapy;The Journal of Clinical Hypertension;2015-07-14

5. Magnitude of Blood Pressure Reduction in the Placebo Arms of Modern Hypertension Trials;Hypertension;2015-02